Q00613 (HSF1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 128.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Heat shock factor protein 1 Short name=HSF 1 Alternative name(s): Heat shock transcription factor 1 Short name=HSTF 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 529 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | DNA-binding protein that specifically binds heat shock promoter elements (HSE) and activates transcription. In higher eukaryotes, HSF is unable to bind to the HSE unless the cells are heat shocked. Ref.7 Ref.9 Ref.10 Ref.11 Ref.13 Ref.14 Ref.15 Ref.18 |
| Subunit structure | Monomer. Under normal conditions, interacts with HSP90AA1 in the HSP90 multichaperone complex; the interaction prevents trimerization and activation of HSF1. On activation by heat-stress or by other factors such as metal ions, HSF1 is released from the complex, homotrimerizes, is hyperphosphorylated and translocated to the nucleus where, subsequently, it can activate transcription. Binds the complex through the regulatory domain. Interacts with SYMPK and CSTF2 in heat-stressed cells. Interacts with FKBP4 in the HSP90 multichaperone complex; the interaction is independent of the phosphorylation state of HSF1. Interacts with MAPKAPK2. Interacts with EEF1D at heat shock promoter elements (HSE). Ref.13 Ref.16 Ref.18 Ref.25 |
| Subcellular location | Cytoplasm. Nucleus. Note: Cytoplasmic during normal growth. On activation, translocates to nuclear stress granules. Colocalizes with SUMO1 in nuclear stress granules. Ref.7 Ref.15 |
| Domain | the 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors. Ref.8 Ref.20 |
| Post-translational modification | Phosphorylated on multiple serine residues, a subset of which are involved in stress-related regulation of transcription activation. Constitutive phosphorylation represses transcriptional activity at normal temperatures. Levels increase on specific residues heat-shock and enhance HSF1 transactivation activity. Phosphorylation on Ser-307 derepresses activation on heat-stress and in combination with Ser-303 phosphorylation appears to be involved in recovery after heat-stress. Phosphorylated on Ser-230 by CAMK2, in vitro. Cadmium also enhances phosphorylation at this site. Phosphorylation on Ser-303 is a prerequisite for HSF1 sumoylation. Phosphorylation on Ser-121 inhibits transactivation and promotes HSP90 binding. Phosphorylation on Thr-142 also mediates transcriptional activity induced by heat. Ref.7 Ref.9 Ref.10 Ref.11 Ref.13 Ref.14 Ref.15 Ref.18 Ref.19 Sumoylated with SUMO1 and SUMO2 on heat-shock. Heat-inducible sumoylation occurs after 15 min of heat-shock, after which levels decrease and at 4 hours, levels return to control levels. Sumoylation has no effect on HSE binding nor on transcriptional activity. Phosphorylation on Ser-303 is a prerequisite for sumoylation. Ref.12 Ref.15 Ref.19 |
| Sequence similarities | Belongs to the HSF family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| MAPKAPK2 | P49137 | 5 | EBI-719620,EBI-993299 | |
| PRKCQ | Q04759 | 2 | EBI-719620,EBI-374762 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform Long (identifier: Q00613-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Short (identifier: Q00613-2) The sequence of this isoform differs from the canonical sequence as follows: 462-489: GKQLVHYTAQPLFLLDPGSVDTGSNDLP → AGALHSAAAVPAGPRLRGHREQRPAGAV 490-529: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 529 | 529 | Heat shock factor protein 1 | PRO_0000124567 | |||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||
| DNA binding | 15 – 120 | 106 | By similarity | ||||||||||||||||||||||||||
| Region | 130 – 203 | 74 | Hydrophobic repeat HR-A/B | ||||||||||||||||||||||||||
| Region | 221 – 310 | 90 | Regulatory domain | ||||||||||||||||||||||||||
| Region | 371 – 529 | 159 | Transactivation domain | ||||||||||||||||||||||||||
| Region | 384 – 409 | 26 | Hydrophobic repeat HR-C | ||||||||||||||||||||||||||
| Motif | 412 – 420 | 9 | 9aaTAD | ||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||
| Modified residue | 121 | 1 | Phosphoserine; by MAPKAPK2 Ref.18 | ||||||||||||||||||||||||||
| Modified residue | 142 | 1 | Phosphothreonine; by CK2 Ref.14 | ||||||||||||||||||||||||||
| Modified residue | 230 | 1 | Phosphoserine Ref.7 | ||||||||||||||||||||||||||
| Modified residue | 292 | 1 | Phosphoserine | ||||||||||||||||||||||||||
| Modified residue | 303 | 1 | Phosphoserine Ref.7 Ref.9 Ref.10 Ref.15 Ref.19 | ||||||||||||||||||||||||||
| Modified residue | 307 | 1 | Phosphoserine Ref.7 Ref.9 Ref.10 Ref.11 | ||||||||||||||||||||||||||
| Modified residue | 314 | 1 | Phosphoserine Ref.21 Ref.23 Ref.24 | ||||||||||||||||||||||||||
| Modified residue | 323 | 1 | Phosphothreonine Ref.17 Ref.23 | ||||||||||||||||||||||||||
| Modified residue | 326 | 1 | Phosphoserine Ref.23 Ref.24 | ||||||||||||||||||||||||||
| Modified residue | 344 | 1 | Phosphoserine | ||||||||||||||||||||||||||
| Modified residue | 363 | 1 | Phosphoserine Ref.22 | ||||||||||||||||||||||||||
| Modified residue | 419 | 1 | Phosphoserine | ||||||||||||||||||||||||||
| Modified residue | 444 | 1 | Phosphoserine | ||||||||||||||||||||||||||
| Cross-link | 298 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.12 Ref.15 Ref.19 | |||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||
| Alternative sequence | 462 – 489 | 28 | GKQLV…SNDLP → AGALHSAAAVPAGPRLRGHR EQRPAGAV in isoform Short. | VSP_002414 | |||||||||||||||||||||||||
| Alternative sequence | 490 – 529 | 40 | Missing in isoform Short. | VSP_002415 | |||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||
| Mutagenesis | 91 | 1 | K → R: No effect on sumoylation. Ref.15 | ||||||||||||||||||||||||||
| Mutagenesis | 120 | 1 | T → A: No effect on binding HSE nor on transcriptional activity. Ref.18 | ||||||||||||||||||||||||||
| Mutagenesis | 121 | 1 | S → A: Increased binding HSE and transcriptional activity. Greatly reduced binding to HSP90AA1. No effect on MAPKAPK2 binding. Ref.18 | ||||||||||||||||||||||||||
| Mutagenesis | 121 | 1 | S → D: Some inhibition of binding HSE and transcriptional activity. No change in binding HSP90AA1. Inhibits MAPKAPK2 binding. Ref.18 | ||||||||||||||||||||||||||
| Mutagenesis | 123 | 1 | S → A: No effect on binding HSE nor on transcriptional activity. Ref.18 | ||||||||||||||||||||||||||
| Mutagenesis | 124 | 1 | T → A: No effect on binding HSE nor on transcriptional activity. Ref.18 | ||||||||||||||||||||||||||
| Mutagenesis | 126 | 1 | K → R: No effect on sumoylation. Ref.15 | ||||||||||||||||||||||||||
| Mutagenesis | 142 | 1 | T → A: Reduced promoter activity by about 90%. Almost no transcriptional activity when coexpressed with CK2. Ref.14 | ||||||||||||||||||||||||||
| Mutagenesis | 150 | 1 | K → R: No effect on sumoylation. Ref.15 | ||||||||||||||||||||||||||
| Mutagenesis | 162 | 1 | K → R: No effect on sumoylation. Ref.15 | ||||||||||||||||||||||||||
| Mutagenesis | 230 | 1 | S → A: No phosphorylation. Impaired transcriptional activity. No change in inducible DNA-binding activity. Ref.7 Ref.15 | ||||||||||||||||||||||||||
| Mutagenesis | 230 | 1 | S → D: Mimics phosphorylation. No effect on transcriptional activity. Ref.7 Ref.15 | ||||||||||||||||||||||||||
| Mutagenesis | 275 | 1 | S → A: Reduced increase in heat-induced transcriptional activity. Ref.11 | ||||||||||||||||||||||||||
| Mutagenesis | 296 | 1 | R → A: No effect on repression of transcriptional activity at control temperature. Ref.9 | ||||||||||||||||||||||||||
| Mutagenesis | 297 | 1 | V → A: Slight effect on repression of transcriptional activity at control temperature. Ref.9 | ||||||||||||||||||||||||||
| Mutagenesis | 298 | 1 | K → A: Derepression of transcriptional activity at control temperature by 18.5%. Ref.9 Ref.12 Ref.15 | ||||||||||||||||||||||||||
| Mutagenesis | 298 | 1 | K → R: Abolishes sumoylation. No effect on phosphorylation of S-303 nor of S-307. No effect on binding to HSE nor on transactivation of HSP70. Ref.9 Ref.12 Ref.15 | ||||||||||||||||||||||||||
| Mutagenesis | 299 | 1 | E → A: No effect on repression of transcriptional activity at control temperature. Ref.9 | ||||||||||||||||||||||||||
| Mutagenesis | 300 | 1 | E → A: Derepression of transcriptional activity at control temperature by 11%. Ref.9 | ||||||||||||||||||||||||||
| Mutagenesis | 303 | 1 | S → A: No phosphorylation nor sumoylation. No change in subcellular location to nuclear stress granules. Slight decrease in transcriptional activity on heat treatment. 2.5-fold increase in transcriptional activity on heat treatment; when associated with A-303. Ref.9 Ref.10 Ref.11 Ref.15 | ||||||||||||||||||||||||||
| Mutagenesis | 303 | 1 | S → D: Mimics phosphorylation. No effect on in vitro sumoylation. Greatly increased transcriptional activity on heat induction. 5-fold derepression of transcriptional activity at control temperature; when associated with A-307. Ref.9 Ref.10 Ref.11 Ref.15 | ||||||||||||||||||||||||||
| Mutagenesis | 307 | 1 | S → A: No phosphorylation. 5-fold derepression of transcriptional activity at control temperature; when associated with A-303. 1.5% increase in transcriptional activity on heat-treatment. 2.5-fold increase in transcriptional activity on heat treatment; when associated with A-303. Ref.9 Ref.10 Ref.11 Ref.15 | ||||||||||||||||||||||||||
| Mutagenesis | 309 | 1 | R → A: No effect on repression of transcriptional activity at control temperature. Ref.9 | ||||||||||||||||||||||||||
| Mutagenesis | 311 | 1 | E → A: No effect on repression of transcriptional activity at control temperature. Ref.9 | ||||||||||||||||||||||||||
| Mutagenesis | 326 | 1 | S → A: Significant increase in transcriptional activity. No effect on DNA binding nor on nuclear translocation. | ||||||||||||||||||||||||||
| Mutagenesis | 363 | 1 | S → A: No effect on sumoylation. Ref.15 | ||||||||||||||||||||||||||
| Mutagenesis | 381 | 1 | K → R: No effect on sumoylation. Ref.15 | ||||||||||||||||||||||||||
| Mutagenesis | 527 | 1 | T → A: No change in binding HSE nor on transcriptional activity. Decreased binding HSE; when associated with A-529. Ref.18 | ||||||||||||||||||||||||||
| Mutagenesis | 529 | 1 | S → A: No change in binding HSE nor on transcriptional activity. Decreased binding HSE; when associated with A-527. Ref.18 | ||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||
| Helix | 17 – 27 | 11 | |||||||||||||||||||||||||||
| Turn | 29 – 34 | 6 | |||||||||||||||||||||||||||
| Beta strand | 35 – 37 | 3 | |||||||||||||||||||||||||||
| Beta strand | 41 – 46 | 6 | |||||||||||||||||||||||||||
| Helix | 49 – 60 | 12 | |||||||||||||||||||||||||||
| Helix | 66 – 75 | 10 | |||||||||||||||||||||||||||
| Beta strand | 79 – 82 | 4 | |||||||||||||||||||||||||||
| Beta strand | 87 – 91 | 5 | |||||||||||||||||||||||||||
| Beta strand | 97 – 100 | 4 | |||||||||||||||||||||||||||
| Helix | 109 – 111 | 3 | |||||||||||||||||||||||||||
| Turn | 112 – 114 | 3 | |||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning and expression of a human heat shock factor, HSF1." Rabindran S.K., Giorgi G., Clos J., Wu C. Proc. Natl. Acad. Sci. U.S.A. 88:6906-6910(1991) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG). |
| [3] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG). |
| [4] | "DNA sequence and analysis of human chromosome 8." Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S., Asakawa T. Lander E.S.Nature 439:331-335(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG). Tissue: Muscle. |
| [6] | "Isolation of a cDNA for HSF2: evidence for two heat shock factor genes in humans." Schuetz T.J., Gallo G.J., Sheldon L., Tempst P., Kingston R.E. Proc. Natl. Acad. Sci. U.S.A. 88:6911-6915(1991) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 73-79; 81-93; 97-106; 163-170 AND 337-352. |
| [7] | "Phosphorylation of serine 230 promotes inducible transcriptional activity of heat shock factor 1." Holmberg C.I., Hietakangas V., Mikhailov A., Rantanen J.O., Kallio M., Meinander A., Hellman J., Morrice N., MacKintosh C., Morimoto R.I., Eriksson J.E., Sistonen L. EMBO J. 20:3800-3810(2001) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 228-241 AND 297-310, PHOSPHORYLATION AT SER-230; SER-303 AND SER-307, FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF SER-230. |
| [8] | "A heat shock-responsive domain of human HSF1 that regulates transcription activation domain function." Green M., Schuetz T.J., Sullivan E.K., Kingston R.E. Mol. Cell. Biol. 15:3354-3362(1995) [PubMed] [Europe PMC] [Abstract] Cited for: DOMAINS. |
| [9] | "Repression of human heat shock factor 1 activity at control temperature by phosphorylation." Knauf U., Newton E.M., Kyriakis J., Kingston R.E. Genes Dev. 10:2782-2793(1996) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-303 AND SER-307, FUNCTION, MUTAGENESIS OF ARG-296; VAL-297; LYS-298; GLU-299; GLU-300; SER-303; SER-307; ARG-309 AND GLU-311. |
| [10] | "Repression of the heat shock factor 1 transcriptional activation domain is modulated by constitutive phosphorylation." Kline M.P., Morimoto R.I. Mol. Cell. Biol. 17:2107-2115(1997) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-303 AND SER-307, FUNCTION, MUTAGENESIS OF SER-303 AND SER-307. |
| [11] | "Transcriptional activation of heat shock factor HSF1 probed by phosphopeptide analysis of factor 32P-labeled in vivo." Xia W., Guo Y., Vilaboa N., Zuo J., Voellmy R. J. Biol. Chem. 273:8749-8755(1998) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-307, FUNCTION, MUTAGENESIS OF SER-275; SER-303 AND SER-307. |
| [12] | "Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification." Hong Y., Rogers R., Matunis M.J., Mayhew C.N., Goodson M.L., Park-Sarge O.K., Sarge K.D. J. Biol. Chem. 276:40263-40267(2001) [PubMed] [Europe PMC] [Abstract] Cited for: SUMOYLATION AT LYS-298, MUTAGENESIS OF LYS-298. |
| [13] | "Evidence for a mechanism of repression of heat shock factor 1 transcriptional activity by a multichaperone complex." Guo Y., Guettouche T., Fenna M., Boellmann F., Pratt W.B., Toft D.O., Smith D.F., Voellmy R. J. Biol. Chem. 276:45791-45799(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH FKBP4 AND HSP90AA1 IN THE HSP90 MULTICHAPERONE COMPLEX, SUBUNIT, PHOSPHORYLATION, FUNCTION. |
| [14] | "Transcriptional activity and DNA binding of heat shock factor-1 involve phosphorylation on threonine 142 by CK2." Soncin F., Zhang X., Chu B., Wang X., Asea A., Ann Stevenson M., Sacks D.B., Calderwood S.K. Biochem. Biophys. Res. Commun. 303:700-706(2003) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT THR-142, FUNCTION, MUTAGENESIS OF THR-142. |
| [15] | "Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1." Hietakangas V., Ahlskog J.K., Jakobsson A.M., Hellesuo M., Sahlberg N.M., Holmberg C.I., Mikhailov A., Palvimo J.J., Pirkkala L., Sistonen L. Mol. Cell. Biol. 23:2953-2968(2003) [PubMed] [Europe PMC] [Abstract] Cited for: SUMOYLATION AT LYS-298, PHOSPHORYLATION AT SER-303, FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-91; LYS-126; LYS-150; LYS-162; SER-230; LYS-298; SER-303; SER-307; SER-363 AND LYS-381. |
| [16] | "HSF1 modulation of Hsp70 mRNA polyadenylation via interaction with symplekin." Xing H., Mayhew C.N., Cullen K.E., Park-Sarge O.-K., Sarge K.D. J. Biol. Chem. 279:10551-10555(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SYMPK AND CSTF2. |
| [17] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-323, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "Phosphorylation of HSF1 by MAPK-activated protein kinase 2 on serine 121, inhibits transcriptional activity and promotes HSP90 binding." Wang X., Khaleque M.A., Zhao M.J., Zhong R., Gaestel M., Calderwood S.K. J. Biol. Chem. 281:782-791(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-121, FUNCTION, INTERACTION WITH HSP90AA1 AND MAPKAPK2, MUTAGENESIS OF THR-120; SER-121; SER-123; THR-124; THR-527 AND SER-529, MASS SPECTROMETRY. |
| [19] | "PDSM, a motif for phosphorylation-dependent SUMO modification." Hietakangas V., Anckar J., Blomster H.A., Fujimoto M., Palvimo J.J., Nakai A., Sistonen L. Proc. Natl. Acad. Sci. U.S.A. 103:45-50(2006) [PubMed] [Europe PMC] [Abstract] Cited for: SUMOYLATION AT LYS-298, PHOSPHORYLATION AT SER-303. |
| [20] | "Nine-amino-acid transactivation domain: establishment and prediction utilities." Piskacek S., Gregor M., Nemethova M., Grabner M., Kovarik P., Piskacek M. Genomics 89:756-768(2007) [PubMed] [Europe PMC] [Abstract] Cited for: DOMAIN. |
| [21] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-314, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [22] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [23] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-314; THR-323 AND SER-326, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [24] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-314 AND SER-326, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [25] | "Transformation of eEF1Bdelta into heat-shock response transcription factor by alternative splicing." Kaitsuka T., Tomizawa K., Matsushita M. EMBO Rep. 12:673-681(2011) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH EEF1D. |
| [26] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M64673 mRNA. Translation: AAA52695.1. AK290975 mRNA. Translation: BAF83664.1. BT007351 mRNA. Translation: AAP36015.1. AC110280 Genomic DNA. No translation available. AF205589 Genomic DNA. No translation available. BC014638 mRNA. Translation: AAH14638.1. | ||||||||||||
| IPI | IPI00024071. IPI00218507. | ||||||||||||
| PIR | A41137. | ||||||||||||
| RefSeq | NP_005517.1. NM_005526.2. | ||||||||||||
| UniGene | Hs.530227. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q00613. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-35670N. | ||||||||||||
| IntAct | Q00613. 8 interactions. | ||||||||||||
| MINT | MINT-230849. | ||||||||||||
| STRING | 9606.ENSP00000332698. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q00613. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 462333. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q00613. | ||||||||||||
| PRIDE | Q00613. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 3297. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000528838; ENSP00000431512; ENSG00000185122. ENST00000570268; ENSP00000455432; ENSG00000261132. | ||||||||||||
| GeneID | 3297. | ||||||||||||
| KEGG | hsa:3297. | ||||||||||||
| UCSC | uc003zbt.4. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 3297. | ||||||||||||
| GeneCards | GC08P145515. | ||||||||||||
| HGNC | HGNC:5224. HSF1. | ||||||||||||
| HPA | CAB004239. HPA008888. | ||||||||||||
| MIM | 140580. gene. | ||||||||||||
| neXtProt | NX_Q00613. | ||||||||||||
| PharmGKB | PA29493. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG5169. | ||||||||||||
| HOGENOM | HOG000253917. | ||||||||||||
| HOVERGEN | HBG005999. | ||||||||||||
| InParanoid | Q00613. | ||||||||||||
| KO | K09414. | ||||||||||||
| OMA | SPLVRVK. | ||||||||||||
| OrthoDB | EOG4VMFFN. | ||||||||||||
| PhylomeDB | Q00613. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| SignaLink | Q00613. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q00613. | ||||||||||||
| Bgee | Q00613. | ||||||||||||
| CleanEx | HS_HSF1. | ||||||||||||
| Genevestigator | Q00613. | ||||||||||||
| GermOnline | ENSG00000185122. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 1.10.10.10. 1 hit. | ||||||||||||
| InterPro | IPR027072. HSF1. IPR000232. HSF_DNA-bd. IPR010542. Vert_HS_TF. IPR011991. WHTH_DNA-bd_dom. [Graphical view] | ||||||||||||
| PANTHER | PTHR10015:SF42. PTHR10015:SF42. 1 hit. | ||||||||||||
| Pfam | PF00447. HSF_DNA-bind. 1 hit. PF06546. Vert_HS_TF. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00056. HSFDOMAIN. | ||||||||||||
| SMART | SM00415. HSF. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS00434. HSF_DOMAIN. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| BindingDB | Q00613. | ||||||||||||
| ChEMBL | CHEMBL5869. | ||||||||||||
| ChiTaRS | HSF1. human. | ||||||||||||
| GenomeRNAi | 3297. | ||||||||||||
| NextBio | 13075. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | HSF1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q00613 Secondary accession number(s): A8K4L0, A8MW26, Q53XT4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 8 Human chromosome 8: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
